BOP1 Silencing Suppresses Gastric Cancer Proliferation through p53 Modulation

Abstract

Block of proliferation 1 (BOP1) is a key protein involved in ribosome maturation and affects cancer progression. However, its role in gastric cancer (GC) remains unknown. This study aimed to explore the expression of BOP1 in GC and its potential mechanisms in regulating GC growth, and the relationship between BOP1 level in cancer tissues and survival was also analyzed. The expression of BOP1 was examined by immunohistochemistry (IHC) in a cohort containing 387 patients with primary GC. Cultured GC cells were treated by siRNA to knock down the BOP1 expression, and examined by CCK-8 assay and plate clone formation to assess cell proliferation in vitro. Apoptotic rate of cultured GC cells was detected by flow cytometry with double staining of AnnxinV/PI. The xenografted mouse model was used to assess GC cell proliferation in vivo. Western blot and IHC were also performed to detect the expression levels of BOP1, p53 and p21. Patients with higher level of BOP1 in cancer tissues had significantly poorer survival. BOP1 silencing significantly suppressed GC cell proliferation both in vitro and in vivo. It blocked cell cycle at G0/G1 phase and led to apoptosis of GC cells via upregulating p53 and p21. BOP1 silencing-induced suppression of cell proliferation was partly reversed by pifithrin-α (a p53 inhibitor). Our study demonstrated that BOP1 up-regulation may be a hallmark of GC and it may regulate proliferation of GC cells by activating p53. BOP1 might be considered a novel biomarker of GC proliferation, and could be a potential indicator of prognosis of GC patients. BOP1 might also be a potential target for the treatment of GC patients if further researched.

Keywords

gastric cancer / block of proliferation 1 / cell proliferation / p53K

References

[1] ShenL, ShanYS, HuHM, et al.. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol, 2013, 14(12): e535-547

[2] LiP, HuangCM, ZhengCH, et al.. Comparison of gastric cancer survival after R0 resection in the US and China. J Surg Oncol, 2018, 118(6): 975-982

[3] BarryKH, MooreLE, SampsonJN, et al.. Prospective study of DNA methylation at chromosome 8q24 in peripheral blood and prostate cancer risk. Br J Cancer, 2017, 116(11): 1470-1479

[4] LiL, LvL, LiangY, et al.. Association of 8q23–24 region (8q23.3 loci and 8q24.21 loci) with susceptibility to colorectal cancer: a systematic and updated meta-analysis. Int J Clin Exp Med, 2015, 8(11): 21001-21013

[5] ShiJ, ZhangY, ZhengW, et al.. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. Int J Cancer, 2016, 139(6): 1303-1317

[6] ZhiP, ShiJ, LiuF. Genetic variations at 8q24 and gastric cancer susceptibility: A meta-analysis study. PLoS One, 2017, 12(12): e0188774

[7] WangX, LiuY, ShaoD, et al.. Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer. Gastric Cancer, 2016, 19(1): 116-127

[8] StrezoskaZ, PestovDG, LauLF. Bop1 is a mouse WD40 repeat nucleolar protein involved in 28S and 5. 8S RRNA processing and 60S ribosome biogenesis. Mol Cell Biol, 2000, 20(15): 5516-5528

[9] StrezoskaZ, PestovDG, LauLF. Functional inactivation of the mouse nucleolar protein Bop1 inhibits multiple steps in pre-rRNA processing and blocks cell cycle progression. J Biol Chem, 2002, 277(33): 29617-29625

[10] ChungKY, ChengIK, ChingAK, et al.. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition. Hepatology, 2011, 54(1): 307-318

[11] QiJ, YuY, Akilli OzturkO, et al.. New Wnt/beta-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals. Gut, 2016, 65(10): 1690-1701

[12] PestovDG, StrezoskaZ, LauLF. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol, 2001, 21(13): 4246-4255

[13] LiuR, IadevaiaV, AverousJ, et al.. Impairing the production of ribosomal RNA activates mammalian target of rapamycin complex 1 signalling and downstream translation factors. Nucleic Acids Res, 2014, 42(8): 5083-5096

[14] EvansDS, KapahiP, HsuehWC, et al.. TOR signaling never gets old: aging, longevity and TORC1 activity. Ageing Res Rev, 2011, 10(2): 225-237

[15] TakadaH, KurisakiA. Emerging roles of nucleolar and ribosomal proteins in cancer, development, and aging. Cell Mol Life Sci, 2015, 72(21): 4015-4025

[16] RubbiCP, MilnerJ. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J, 2003, 22(22): 6068-6077

[17] RohrmoserM, HolzelM, GrimmT, et al.. Interdependence of Pes1, Bop1, and WDR12 controls nucleolar localization and assembly of the PeBoW complex required for maturation of the 60S ribosomal subunit. Mol Cell Biol, 2007, 27(10): 3682-3694

[18] JamesA, WangY, RajeH, et al.. Nucleolar stress with and without p53. Nucleus, 2014, 5(5): 402-426

[19] ScalaF, BrighentiE, GovoniM, et al.. Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate. Oncogene, 2016, 35(8): 977-989

[20] VikhanskayaF, SiddiqueMM, Kei LeeM, et al.. Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs. Clin Cancer Res, 2005, 11(12): 4348-4356

[21] TranTQ, LowmanXH, ReidMA, et al.. Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction. Oncogene, 2017, 36(14): 1991-2001

[22] RasulA, DingC, LiX, et al.. Dracorhodin perchlorate inhibits PI3K/Akt and NF-kappaB activation, up-regulates the expression of p53, and enhances apoptosis. Apoptosis, 2012, 17(10): 1104-1119

[23] BursacS, BrdovcakMC, PfannkuchenM, et al.. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proc Natl Acad Sci USA, 2012, 109(50): 20467-20472

[24] JinA, ItahanaK, O’KeefeK, et al.. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol, 2004, 24(17): 7669-7680

[25] BornkammGW, BerensC, Kuklik-RoosC, et al.. Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Res, 2005, 33(16): e137